Skip to main content Skip to main navigation menu Skip to site footer

The effect of intraarterial heparin flushing to autism symptoms when used to treat the concomitant cerebral venous thrombosis: a case series



Abstract

Introduction. There are still no definite therapeutic strategies for Autism Spectrum Disorder (ASD) other than behavioural interventions and few FDA approved behaviour control drugs. In this study, we found a co-existence medical condition of ASD & Cerebral Vein Thrombosis (CVT) in the paediatric population. Based on these findings, a new therapeutic approach, a catheter-directed anticoagulant therapy termed as IAHF (Intra Arterial Heparin Flushing) was performed on this population of patients.

Methods. This paper aims to describe a series of 10 cases of IAHF procedure performed to treat CVT on children with ASD from 2018 through 2019 at Cerebrovascular Center RSPAD Gatot Soebroto Jakarta-Indonesia. The children diagnosed with ASD by the multidisciplinary team but also had CVT findings on their brain magnetic resonance imaging studies when performed as the series of comprehensive diagnostic examination. IAHF were conducted by delivering heparin through a modified DSA technique into the occluded vessels. Subject Autism status was assessed with the Childhood Autism Rating Scale (CARS) before and one month after IAHF procedures.

Results. The measurement of CARS Score after IAHF shows a relatively positive result. Eight patients showed a decreased in total CARS Score after the procedure, while only two patients had no improvement. One subject shows a decrease of nine points, the most significant changes, and improved the status from moderate to mild autism.

Conclusion. In children who have ASD and also accompanied by CVT findings in their imaging studies, IAHF treatment showed clinical improvement of the autism symptoms.

 

Keywords: Childhood Autism Rating Scale Autism Spectrum Disorder Cerebral Venous Thrombosis Intraarterial heparin flushing

References

  1. Berger P., Schorsch E. Remarks concerning the concept of autism. Nervenarzt. 1969;40(10):454–9.
  2. Ajuriahuerra J. Manual de psiquiatria infantil. 4th ed. Barcelona: Toray-Masson; 1977.
  3. Ronald A. Problem children problem parents. Indian J Pediatr. 1944;11:20–9.
  4. Baird G. Diagnosis of autism. BMJ. 2003;327(7413):488–93.
  5. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington; 1994.
  6. Rutter M., WHO. Multiaxial classification of child and adolescent psychiatric disorders : the ICD-10 classification of mental and behavioural disorders in children and adolescents [Internet]. Cambridge : Cambridge University Press; 1996. p. 302.
  7. Lord C., Jones R.M. Annual Research Review: Re-thinking the classification of autism spectrum disorders. J Child Psychol Psychiatry. 2012;53(5):490–509.
  8. Chawarska K., Klin A., Paul R., Volkmar F. Autism spectrum disorder in the second year: stability and change in syndrome expression. J Child Psychol Psychiatry. 2007;48(2):128–38.
  9. De Giacomo A., Fombonne E. Parental recognition of developmental abnormalities in autism. Eur Child Adolesc Psychiatry. 1998;7(3):131–6.
  10. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, D.C.; 2013.
  11. Gadia C.A., Tuchman R., Rotta N.T. Autismo e doenças invasivas de desenvolvimento. J Pediatr (Rio J). 2004;80(2):83–94.
  12. Al-Odaib A., Merza H., Harbi S., Ozand P. Autism: a review. J Pediatr Neurol. 2015;01(02):55–67.
  13. Landa R.J. Diagnosis of autism spectrum disorders in the first 3 years of life. Nat Clin Pract Neurol. 2008;4(3):138–47.
  14. Mundy P. Normal versus High functioning status in children with autism. Am J Ment Retard. 1993;97:381–4.
  15. Huerta P.T., Kowal C., DeGiorgio L.A., Volpe B.T., Diamond B. Immunity and behavior: Antibodies alter emotion. Proc Natl Acad Sci. 2006;103(3):678–83.
  16. Yang C.-J., Tan H.-P., Du Y.-J. The developmental disruptions of serotonin signaling may involved in autism during early brain development. Neuroscience. 2014;267:1–10.
  17. Bailey A. A clinicopathological study of autism. Brain. 1998;121(5):889–905.
  18. Courchesne E., Karns C.M., Davis H.R., Ziccardi R., Carper R.A., Tigue Z.D., et al. Unusual brain growth patterns in early life in patients with autistic disorder: An MRI study. Neurology. 2001;57(2):245–54.
  19. Schultz R.T., Gauthier I., Klin A., Fulbright R.K., Anderson A.W., Volkmar F., et al. Abnormal Ventral Temporal Cortical Activity During Face Discrimination Among Individuals With Autism and Asperger Syndrome. Arch Gen Psychiatry. 2000;57(4):331.
  20. Smalley S.L., Kustanovich V., Minassian S.L., Stone J.L., Ogdie M.N., McGough J.J., et al. Genetic Linkage of Attention-Deficit/Hyperactivity Disorder on Chromosome 16p13, in a Region Implicated in Autism. Am J Hum Genet. 2002;71(4):959–63.
  21. Pintomartin J., Levy S. Early diagnosis of Autism spectrum disorders. J Neurobiol. 2004;101:344–54.
  22. Jolliffe T., Baron-Cohen S. A test of central coherence theory: linguistic processing in high-functioning adults with autism or Asperger syndrome: is local coherence impaired? Cognition. 1999;71(2):149–85.
  23. Manolitsi M., Botting N. Language abilities in children with autism and language impairment: using narrative as a additional source of clinical information. Child Lang Teach Ther. 2011;27(1):39–55.
  24. Melogno S., Pinto M.A., Levi G. Profile of the linguistic and metalinguistic abilities of a gifted child with autism spectrum disorder: A case study. Child Lang Teach Ther. 2014;31(1):113–26.
  25. Rossignol D.A., Frye R.E. A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures. Mol Psychiatry. 2011;17(4):389–401.
  26. Whiteley P., Todd L., Carr K., Shattock P. Gender Ratios in Autism, Asperger Syndrome and Autism Spectrum Disorder. Autism Insights. 2010;2:17–24.
  27. Prior M. Intensive behavioural intervention in autism. J Paediatr Child Health. 2004;40(9–10):506–7.
  28. Volkmar F., Siegel M., Woodbury-Smith M., King B., McCracken J., State M. Practice Parameter for the Assessment and Treatment of Children and Adolescents With Autism Spectrum Disorder. J Am Acad Child Adolesc Psychiatry. 2014;53(2):237–57.
  29. Leclerc S., Easley D. Pharmacological Therapies For Autism Spectrum Disorder: A Review. Pharm Ther. 2015;40(6):389.
  30. Politte L.C., McDougle C.J. Atypical antipsychotics in the treatment of children and adolescents with pervasive developmental disorders. Psychopharmacology (Berl). 2013;231(6):1023–36.
  31. Calvert J.W., Cahill J., Zhang J.H. Hyperbaric oxygen and cerebral physiology. Neurol Res. 2007;29(2):132–41.
  32. Rossignol D.A., Rossignol L.W., Smith S., Schneider C., Logerquist S., Usman A., et al. Hyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trial. BMC Pediatr. 2009;9(21):1–15.
  33. Hashmi M., Wasay M. Caring for cerebral venous sinus thrombosis in children. J Emerg Trauma Shock. 4(3):389–94.
  34. Dlamini N., Billinghurst L., Kirkham F.J. Cerebral venous sinus (sinovenous) thrombosis in children. Neurosurg Clin N Am. 2010;21(3):511–27.
  35. Carvalho K.S., Bodensteiner J.B., Connolly P.J., Garg B.P. Cerebral venous thrombosis in children. J Child Neurol. 16(8):574–80.
  36. Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med. 352(17):1791–8.
  37. Saposmik G., Barinagarrementeria F., Brown R., Bushnell C., Cucchiara B., Cushman M. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:1158–92.
  38. Sébire G., Tabarki B., Saunders D.E., Leroy I., Liesner R., Saint-Martin C., et al. Cerebral venous sinus thrombosis in children: risk factors, presentation, diagnosis and outcome. Brain a J Neurol. 2005;128(3):477–89.
  39. Wiryadana K.A., Supadmanaba I.G.P., Samatra D.P.G.P. Progress and potential roles blood biomarkers of ischemic stroke in clinical setting. Indones J Biomed Sci. 2017;11(2):19–29.
  40. Yoon N.K., McNally S., Taussky P., Park M.S. Imaging of cerebral aneurysms: a clinical perspective. Neurovascular Imaging. 2016;2(6):1–7.
  41. Putranto T., Yusuf I., Murtala B., Wijaya A. Intra Arterial Heparin Flushing Increases Manual Muscle Test-Medical Research Councils (MMT-MRC) Score in Chronic Ischemic Stroke Patient. Bali Med J. 2016;5(2):216–20.
  42. Fombonne E. Epidemiological surveys of autism and other pervasive developmental disorders: an update. J Autism Pervasive Dev Disord. 2003;33(4):365–82.
  43. Malone R.P., Waheed A. The Role of Antipsychotics in the Management of Behavioural Symptoms in Children and Adolescents with Autism. Drugs. 2009;69(5):535–48.

How to Cite

Setiawan, E., Soetikno, R., Risan, N. A., Shelly, S., Ratmono, T., Pramono, A., Adiputra, R. H. S., & Putranto, T. A. (2019). The effect of intraarterial heparin flushing to autism symptoms when used to treat the concomitant cerebral venous thrombosis: a case series. Bali Medical Journal, 8(3), 713–718. https://doi.org/10.15562/bmj.v8i3.1609
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver
Download Citation
Endnote/Zotero/Mendeley (RIS) BibTeX

HTML
1

Total
20

Share

Search Panel

Erwin Setiawan
Google Scholar
Pubmed
BMJ Journal

Ristaniah Soetikno
Google Scholar
Pubmed
BMJ Journal

Nelly Amalia Risan
Google Scholar
Pubmed
BMJ Journal

Shelly Shelly
Google Scholar
Pubmed
BMJ Journal

Tugas Ratmono
Google Scholar
Pubmed
BMJ Journal

Ardianto Pramono
Google Scholar
Pubmed
BMJ Journal

Rachmanto Heryawan Surya Adiputra
Google Scholar
Pubmed
BMJ Journal

Terawan Agus Putranto
Google Scholar
Pubmed
BMJ Journal